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Background: Bacterial meningitis is more common in the neonatal period than any other time in life; however, it is
still a challenge for the evidence based diagnosis. Strategy for identification of neonatal bacterial meningitis
pathogens is presented by evaluating three different available methods to establish evidence-based diagnosis for
neonatal bacterial meningitis.
Methods: The cerebrospinal fluid samples from 56 neonates diagnosed as bacterial meningitis in 2009 in Beijing
Children’s Hospital were analyzed in the study. Two PCR based molecular assays, real-time fluorescence quantitative
PCR (RT-PCR) and multiplex PCR based-reverse line blot hybridization (mPCR/RLB), were used to assess 7 common
neonatal meningitis bacterial pathongens, including Escherichia coli, Staphylococcus aureus, Listerisa monocytogenes,
Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae, and Streptococcus agalactiae. The findings
in examinations of two assays were compared with the results obtained bacterial culture tests.
Results: Bacterial meningitis was identified in five cases (9%) by CSF cultures, 25 (45%) by RT-PCR and 16 (29%) by
mPCR/RLB. One strain of S. epidermidis and one of E. faecalis were identified using mPCR/RLB but not by RT-PCR. In
contrast, cultures identified one strain of S. pneumoniae which was missed by both PCR assays. Overall, the bacterial
pathogens in 28 cases were identified with these three methods. Both RT-PCR and mPCR/RLB assays were more
sensitive than bacterial culture, (p < 0.05).
Conclusion: Our study confirmed that both RT-PCR and mPCR/RLB assays have better sensitivity than bacterial
culture. They are capable of detecting the pathogens in CSF samples with negative culture results.
Keywords: Neonate, Bacterial meningitis, Bacterial pathogens identification, Multiplex real-time fluorescence quantitative
PCR (RT-PCR), Multiplex PCR based-reverse line blot hybridization (mPCR/RLB) assay, Bacteria culture* Correspondence: cxswyj@vip.sina.com
1Neonatal Center, Beijing Children’s Hospital, Capital Medical University,
Beijing 100045, China
Full list of author information is available at the end of the article
© 2014 Wang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Wang et al. BMC Pediatrics 2014, 14:224 Page 2 of 8
http://www.biomedcentral.com/1471-2431/14/224Background
Bacterial meningitis is more common in the neonatal
period than any other time in life [1-4]. A recent review
on neonatal infections reports that the incidence of
meningitis ranges from 0.8 to 6.1 cases per 1,000 live
newborns [5]. The World Health Organization (WHO)
estimates that there are approximately 5 million neonatal
deaths a year, and the fatality rate of neonatal meningitis is
as high as 50% [6,7]. The overwhelming majority (98%) of
fatal cases of neonatal meningitis occurs in developing
countries. Moreover, 21% to 50% of the survivors show
neurological sequelae with hydrocephalus, blindness, hear-
ing loss, paralysis, and mental retardation [4].
Signs and symptoms of neonatal bacterial meningitis
may be subtle, nonspecific, vague, and atypical. A high
index of suspicion is therefore needed to initiate investi-
gations. Further, the identification of specific organisms
and their sensitivity is important for the judicious and
rational use of antimicrobial agents. No single cerebro-
spinal fluid (CSF) value can be used to exclude meningi-
tis, and peripheral WBC counts are poor predictors of
neonatal meningitis [8]. Currently, few techniques for
the rapid diagnosis of neonatal bacterial meningitis are
available, and the commercial molecular tests are gener-
ally too expensive for developing countries. The bacter-
ial culture remains as the gold standard though there is
low recovery rate of pathogens.
Non-culture methods, such as multiplex real-time fluor-
escence quantitative PCR (RT-PCR) and multiplex poly-
merase chain reaction (mPCR)-based reverse line blot
(RLB) hybridization assays are reliable and accurate tests
which could increase the diagnostic yield of bacterial men-
ingitis [9-13]. Both RT-PCR and mPCR/RLB assays have
been used as excellent tool in epidemiologic studies
[14,15]. The RT-PCR assay has characteristic of high
sensitivity in CSF [10]; the mPCR/RLB approach is
suited for the batched simultaneous analysis of large
numbers of isolates [15].
The aim of this study was to evaluate the optimal
strategy for identification of bacterial pathogens in neo-
natal bacterial meningitis based on the three methods in-
cluding RT-PCR, mPCR/RLB and CSF bacterial culture.
Methods
Patient selection
This is a cross sectional design study. This study enrolled
newborns with bacterial meningitis aged between 0 to
28 days admitted to the neonatal department in Beijing
Children’s Hospital, affiliated to Capital Medical Univer-
sity in 2009. The bacterial meningitis was diagnosed based
on clinical presentation, abnormal laboratory tests and
CSF culture [16]. The diagnostic laboratory criteria for
bacterial meningitis included the following: presence
of >20 leukocytes/mm3, predominance of neutrophils;protein concentration in cerebrospinal fluid >150 mg/dL;
hypoglycorrhachia <1.1-2.2 mmol/L or <50%-75% of the
concomitant blood glucose concentration; identification of
bacteria on microscopy and/or culture of eliminate CSF.
The clinical manifestations suggestive of neonatal menin-
gitis included lethargy, vomiting, convulsions, irritability,
refuses to feed, tremors and bulging fontanels. The exclu-
sion criteria consisted of central nervous system malfor-
mations, meningitis after cranio-encephalic trauma, and
viral or fungal meningitis.
Our study was agreed by the Research Ethical Review
Committee, Beijing Children’s Hospital Affiliated to Capital
Medical University. The written consent informs were
obtained from the parents of all participants.
CSF samples
The initial CSF samples were used for analysis, which
were collected by an experienced physician under aseptic
condition. The volume, turbidity, cells, protein and glu-
cose concentration of CSF samples were measured. 100 μl
of CSF was inoculated onto each bacterial culture plate.
The remaining samples were placed into two sterile tubes,
(0.5-1 ml), and stored at −70°C.
Bacterial isolates
Reference strains of 7 bacterial species - Escherichia coli,
Staphylococcus aureus, Listerisa monocytogenes, Neisseria
meningitidis, Haemophilus influenzae, Streptococcus pneu-
moniae, and Streptococcus agalactiae, as listed in Table 1,
were used to develop the assays. RT-PCR and mPCR/RLB
were developed to detect the target genes of the specific
pathogens from prior clinical isolates. All clinical iso-
lates were identified according to conventional standard
methods.
DNA extraction
DNA extraction was performed using QIAGEN QIAamp
DNA Blood mini kit (QIAGEN, Shanghai, China) follow-
ing the product instruction. An aliquot of 200 μL of CSF
was processed and the DNA was eluted in 100 μL of TE
buffer.
RT-PCR
A RT-PCR assay on Mx3000P QPCR Systems (Stratagene,
USA) was used to identify seven common pathogens that
cause neonatal bacterial meningitis.
Primer and probe design
Species-specific primers and probes were designed,
followed previously validated methods, to allow ampli-
fication [17-21]. The details of the primers and the
probes in this assay are shown in Table 2.
The assays were carried out in a final 20 μL reaction
volume and were performed using 2 × PCR Premix Ex





isolates (No)Target gene Detection limit Genome
copies/μL
Target gene Detection limit Genome
copies/μL
E. coli ATCC 25922 16S rRNA 2 fg 0.3 16S rRNA 500 fg 90 6
S. aureus ATCC 25923 femA 200 fg 63 nuc 500 fg 160 9
L. monocytogenes ATCC 19112 hly 200 fg 62 hly 50 fg 15 2
N. meningitides ATCC 29019 ctrA 20 fg 8 ctrA 500 fg 200 2
S. pneumoniae SSI serotype 14 lytA 200 fg 90 ply 500 fg 230 7
H. influenza ATCC 10211 bexA 20 fg 10 gyrB 500 fg 255 10
S. agalactiae ATCC A2 cfb 200 fg 91 cfb 500 fg 228 5
Abbreviations: ATCC – American Type Culture Collection.
Genome copies/μl = concentration (ng/μl) × 6.02 × 1023 × 10−9/660× whole genome nucleotide number. The number of whole-genome nucleotide: E. coli-5498450-bp,
S. aureus-2902619-bp, L. monocytogenes-2944528-bp, N. meningitides-2194961-bp, S. pneumoniae −2046115-bp, H. influenza-1830138-bp, S. agalactiae −2160267-bp.
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Forward primer, reverse primer, and probe for each gene
target were mixed. The probes were labeled at the 5′ end
with FAM and HEX, respectively. RT-PCR was performed
at 95°C for 2 min, followed by 35–50 cycles of 95°C for
5 sec and 60-73°C for 20 sec (see Table 3 for detail).
Analytical sensitivity and specificity
DNA was extracted from reference strains using a DNA
Miniprep Extraction kit (Sigma, St Louis, MO, USA)Table 2 Primers and probes used in RT-PCR assay
Specificity Target Primer and probe sequen
E.coli 16S rRNA F GGGAGTAAAGTTAATACCTT
R CTCAAGCTTGCCAGTATCAG
Probe FAM-CGCGATCACTCCGTGC
L.monocytogenes hly F CAT GGCACCACCAGC ATCT
R ATC CGCGTGTTTCTTTTCGA
Probe HEX-CGCCTG CAA GTC CTA
S. aureus femA F TGCTGGTGGTACATCAAA
R ACGGTCAATGCCATGATTTAA
Probe FAM-ATTTTGCCGGAAGTTAT
N. meningitidis ctrA F TGTGTTCCGCTATACGCCATT
R GCCATATTCACACGATATACC
Probe FAM-AACCTTGAGCAA“T”CC
H. influenzae bexA F TGCGGTAGTGTTAGAAAATG
R GGACAAACATCACAAGCGGT
Probe HEX-ACAAAGCGTATCAA“T”A
S. pneumoniae lytA F ACGCAATCTAGCAGATGAAG
R TCGTGCGTTTTAATTCCAGCT
Probe FAM-TGCCGAAAACGCTTGA
S. agalactiae cfb F CGCAATGAAGTCTTTAATTTT
R ATGATGTATCTATCTGGAACTaccording to the manufacturer’s instructions, and was
tested against all primer sets. The lower limit of detec-
tion (LLD) was determined using extracted DNA from
one isolate each of E. coli, S. aureus, L. monocytogenes, N.
meningitidis, S. pneumoniae, H. influenzae, and group B
streptococci. DNA concentration was adjusted to 100 ng/
mL from which serial ten-fold dilutions of genomic DNA
were prepared in distilled water. In addition, serial ten-fold
dilutions of suspensions of cultures of seven bacteria were
















Table 3 Thermal profiles of RT-PCR
Specificity Thermal profiles
N. meningitides 95°C for 2 min, followed by 50 cycles




L.monocytogenes 95°C for 2 min, followed by 50 cycles
of 95°C for 5 sec and 63°C for 20 sec
E.coli 95°C for 30 sec, followed by 50 cycles of
95°C for 15 sec, 50°C for 30 sec and 75°C 20s
S. agalactiae 95°C for 30 sec, followed by 35 cycles of
94°C for 10 sec, 60°C for 15 sec and 72°C for 25s








Early (<1 week) 15 (27)
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10 min.Jaundice 23 (41%)
convulsion 10 (18%)
Signs
Bulging fontanelle 21 (38%)mPCR/RLB
The mPCR/RLB assay was used to identify the seven
pathogens, same as shown in Table 1.Limb muscle tension change 14 (25%)
Table 5 Laboratory data of 56 neonatal infants
Characteristics All patients (n = 56)
Blood
Peripheral white cell count
9Primer and probe design
Species-specific primers and probes were designed, based
on a previously validated method [4]. Primers were labeled
at the 5′end with biotin to allow PCR products to be de-
tected by hybridization with a streptavidin–peroxidase
substrate in the RLB assay. All probes were labeled at the
5′end with an amine group to facilitate covalent linkage to
nylon membranes and to allow membranes to be stripped
and reused repeatedly.(×10 /l) 22 (39%)
0- 34 (61%)
15-









The mPCR mixture containing 14 primer-pairs included
5 μL DNA extract, 0.25 μL each forward (50 umol ⁄ L) and
reverse (50 μmol ⁄L) primer, 1.25 μL dNTPs mix (2.5 mM
each dNTP), 2.5 μl 10 × PCR buffer, 4.5 mM MgCl2 (final
concentration), 3uL Hotstar Taq DNA polymerase (Qiagen,
Shanghai, China) and water to 25 μL. mPCR was per-
formed in single tube at 95°C for 15 min, followed by
35 cycles of 94°C for 30 sec, 60°C for 30 sec and 72°C
for 1 min, finally by 72°C for 10 min. The development
of RLB hybridization assay was described in previous






CSF culture positive 5 (9%)Analytical specificity and sensitivity for mPCR/RLB
Extraction of DNA and adjustment of DNA concentra-
tion were performed with same operations as RT-PCR.
In addition, serial ten-fold dilutions (starting at 105 CFU⁄mL)
of suspensions of cultures of Escherichia coli ATCC 25922
and Streptococcus pneumoniae SSI 14 were prepared in
physiological saline.
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Statistical analyses were performed using the SPSS 19.0
software. Chi squared test was used to compare to the
sensitivity of identified pathogens by assay and CSF cul-




56 infants were enrolled in the study. The written in-
formed consent was obtained from the parents of all
participants. The clinical characteristics of the 56 infants
are shown in Table 4.The mean gestational age (GA) of
infants was 38 weeks. The mean birth weight was
3.10 kg and 64% of them were male. The majority (73%)
of the infants presented clinical symptoms after 1 week
of life. Most (91%) of the infants had fever. Thirty-sixTable 6 Primers and probes used in mPCR/RLB assay.
Specificity Primer/probe Target Tm (°C) GenBan
accessio
S. aureus SanucSb nuc 65.68 V01281
S. aureus SanucAb nuc 69.12 V01281
S. aureus SanucSp nuc 61.06 V01281
S. aureus SanucAp nuc 61.36 V01281
S. pneumoniae SpplySb ply 67.47 M17717
S. pneumoniae SpplyAb ply 61.68 M17717
S. pneumoniae SpplySp ply 65.44 M17717
S. pneumoniae SpplyAp ply 65.49 M17717
L.monocytogenes LmhlySb hly 67.37 M24199
L.monocytogenes LmhlyAb hly 63.8 M24199
L.monocytogenes LmhlySp hly 68.2 M24199
L.monocytogenes LmhlyAp hly 65.33 M24199
S. agalactiae GBScfbSb cfb 59.53 X72754
S. agalactiae GBScfbAb cfb 60.48 X72754
S. agalactiae GBScfbSp cfb 59.74 X72754
S. agalactiae GBScfbAp cfb 58.55 X72754
N. meningitidis NmctrASb ctrA 66.14 AF52090
N. meningitidis NmctrAAb ctrA 66.36 AF5209
N. meningitidis NmctrASp ctrA 64.1 AF5209
N. meningitidis NmctrAAp ctrA 63.76 AF5209
H. influenzae HigyrBSb gyrB 62.57 U32738
H. influenzae HigyrBAb gyrB 63.68 U32738
H. influenzae HigyrBSp gyrB 62.96 U32738
H. influenzae HigyrBAp gyrB 63.57 U32738
E.coli Ecoli16SSb 16SrRNA 65.74 J01859
E.coli Ecoli16SAb 16SrRNA 68.03 J01859
E.coli Ecoli16SSp 16SrRNA 65.93 J01859
E.coli Ecoli16SAp 16SrRNA 63.71 J01859infants (68%) had been treated with antimicrobials be-
fore hospitalization.
Results of laboratory test of the 56 infants are shown
Table 5. The initial median WBC was 18.03 × 109/L, and
34 of the infants (61%) had leukocytosis with > 15 × 109/L.
CRP was elevated in 21cases (>8 mg/L).Clinical microbiology
Five CSF (9%) bacterial cultures were positive: two L.
monocytogenes, one each of S. pneumoniae, E. faecalis,
and S. epidermidis, respectively. Bacteria were isolated from
blood cultures of nine patients (16%).Primers and probes
Target genes for each species, primer/probe sequences,
and specificities, locations within target genes, numberedk
n No.
Primer and probe sequence (5′-3′) Application
product (bp)
GCG ATT GAT GGT GAT ACG GTT
278
AGC CAA GCC TTG ACG AAC TAA AGC
GAT GGA AAA ATG GTA AAC GAA G
CAT TGG TTG ACC TTT GTA CAT TAA
CCC ACT CTT CTT GCG GTT GA
208
TGA GCC GTT ATT TTT TCA TAC TG
CCC AGC AAT TCA AGT GTT CG
CCA CTT GGA GAA AGC TAT CGC T
CAT GGC ACC ACC AGC ATC T
135
CAC TGC ATC TCC GTG GTA TAC TAA
GAA AAG AAA CAC GCG GAT GAA ATC
TGG CGT CTT AGG ACT TGC AG
ATG ATG TAT CTA TCT GGA ACT CTA GTG
259
CGC AAT GAA GTC TTT AAT TTT TC
ATC AAA GAT AAT GTT CAG GGA AC
TAC TTC TAA TAC AGC TGG TGA AAA
9 GCT GCG GTA GGT GGT TCA A
110
TTG TCG CGG ATT TGC AAC TA
ACG AAC TGT TGC CTT GGA AG
ATT GCC ACG TGT CAG CTG
GAA GCA CAG TCA TAA TAA CTT CTG CT
233
AGC GTC CTG GTA TGT ATA TCG G
TTG CAC CGA TAC AGA ATT ATC ATC
CGG GAT TCC TGT GGA TAT TC
ATG CCG CGT GTA TCA AGA A
93
TAA CGT CAA TGA GCA A
GGG GAG GAA GGG AGT AAA GT
AGT ACT TTA CAA CCC GAA GGC
Figure 1 Detection of 16 standard strains using the mPCR/RLB assay.
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in Table 6.
Results of the RT-PCR and mPCR/RLB analysis
The criteria for positive diagnostic hybridization was
that at least one species-specific oligonucleotide probe
gave a positive signal. Detection limits of the RT-PCR
analysis varied among the 7 reference strains, from 2 to
200 fg of genomic DNA and mPCR/RLB from 50 to
500 fg of genomic DNA (Table 1). The sensitivity of the
assay was from 0.3 to 91 cfu/μL for RT-PCR assay, and
from 15 to 255 cfu/μL for mPCR/RLB assay (Table 1).
None of the species-specific probes cross-reacted with
any non-target species among the reference strains or
clinical isolates (Figure 1 Detection of 16 standard
strains using the mPCR/RLB assay).
Detection of potential pathogens in CSF by RT-PCR and
mPCR/RLB assays
Positive RT-PCR findings were detected in 25 of 56 CSF,
including E. coli (10), S. aureus (7), S. pneumonia (3), L.Table 7 Comparison of Results of RT-PCR and mPCR/RLB
Clinical Specimens
RT-PCR (N = 56) Total
+ -
mPCR/RLB + 14 (25.0%) 2 (3.6%) 16 (28.6%)
- 11 (19.6%) 29 (51.8%) 40 (71.4%)
Total 25 (44.6%) 31 (55.4%) 56monocytogenes (2), group B streptococci (2), and N.
meningitidis (1).
16 CSF specimens of 56 cases were identified with posi-
tive mPCR/RLB, which consisted of E. coli (6), S. aureus
(2), L. monocytogenes (2), group B streptococci (2), S.
pneumonia (1), and N. meningitides (1). Two positive re-
sults by this assay required further analysis to be identified
as S. epidermidis and E. faecalis.
Comparison of RT-PCR assay with mPCR/RLB assay and
CSF bacterial cultures
Overall, there were 28 cases with positive finding with
these three test methods (bacterial culture, RT-PCR
mPCR), indicating presence of pathogens. In one case,
S. pneumonia was positive by culture only and negative
by assay analysis. In two other cases, culture and
mPCR/RLB were positive (S. epidermidis and E. faeca-
lis), but the RT-PCR assay was negative. Biostatistics
results are shown in Tables 7, 8 and 9. In brief, both
RT-PCR and mPCR/RLB assays were more sensitive than
bacterial culture in identification of pathogens, (p < 0.05), inTable 8 Comparison of Results of RT-PCR and cultures
Cultures(N = 56) Total
+ -
RT-PCR + 2 (3.5%) 23 (41.1%) 25(44.6%)
- 3 (5.4%) 28 (50.0%) 31 (55.4%)
Total 5(8.9%) 51(91.1%) 56
χ2 = 13.885, P < 0.05.
Table 9 Comparison of Results of mPCR/RLB and cultures
Cultures (N = 56) Total
+ -
mPCR/RLB + 4 (80.0%) 12 (23.5%) 16 (28.6%)
- 1 (20.0%) 39 (76.5%) 40 (71.4%)
Total 5 (8.9%) 51 (91.1%) 56
χ2 = 7.092, P < 0.05
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(p < 0.05).
Discussion
It is critical important for rapid and specific identifica-
tion of the causative agent in CSF and decision of opti-
mal therapy in the clinical management of neonatal
bacterial meningitis. CSF culture is routine laboratory
tool and current gold standard for the diagnosis of neo-
natal bacterial meningitis in clinical practice. However,
there are only small amount of positive CSF culture in
the samples of neonatal bacterial meningitis [22]. There-
fore, it would be diagnostic dilemma for the patients
with negative CSF culture. Another disadvantage of CSF
culture is that it needs up to 72 h for final identification.
Molecular methods, including RT-PCR and mPCR/
RLB, do not depend on the presence of viable or grow-
ing bacteria, and thus are suitable to the detection of
pathogens that cannot be cultured readily by routine
methods, or that have been partially killed by exposure
to antibiotics [6]. Our study shows RT-PCR and mPCR
could be used for the identification of usual pathogens
that cause meningitis in the newborn period. Both
RT-PCR and mPCR/RLB are more rapid than culture
[23]; RT-PCR can generally be completed two to three
hours, and seven hours for mPCR/RLB. The consum-
able cost of RT-PCR and mPCR/RLB (U$ 20/specimen
and U$ 7/specimen respectively) is more expensive
than the culture with which cost of U$ 2/specimen.
mPCR/RLB assay, a molecular diagnostic tool, is based
on the use of primers and probes that recognize conserved
species-specific sequences of bacterial genes encoding es-
sential molecules [17]. In this study, none of the species-
specific probes cross-reacted with any non-target species
among the reference strains or clinical isolates suggested
its high specificity because using two probes for each
target. Analysis of amplicons in the mPCR/RLB assay
is more sensitive and faster than cultures, and 101 to
102 times more sensitive than common PCR [17]. A
particular advantage of mPCR⁄ RLB is that the mem-
branes can also be stripped and re-used up to 20 times
without substantial loss of sensitivity [9]. The mPCR⁄
RLB method is potentially suitable for use with largenumbers of specimens – like retrospective investigation
and epidemiological surveillance, as it can analyze 43 clin-
ical samples simultaneously.
In this study, 38 (68%) patients had been treated with
antimicrobials before hospitalization, which could con-
tributed to the low yield from CSF 6 (11%) and blood 9
(16%) cultures. At least one pathogen was identified in
16 (29%) of patients by using of mPCR/RLB and 25 (45%)
by RT-PCR, respectively. This indicates that mPCR/RLB
and RT-PCR (in particular) is significantly more sensitive
than culture.
In this study, there was better correlation between cul-
ture and mPCR/RLB than the RT-PCR assay. RT-PCR
failed to identify some specimens (S. epidermidis and E.
faecalis) that were positive by culture and mPCR/RLB,
which may be related with lack of corresponding RT-
PCR primers and probes. In one case, mPCR/RLB did
not identify S. pneumoniae, which grew on culture. This
result may reflect inappropriate long term stored speci-
mens (as a retrospective study), and/or the presence of
mutations in the target regions of probes. The agreement
between the two molecular methods was good. Overall,
RT-PCR was relatively easy to perform and more sensitive
than mPCR/RLB, suggesting that it is a useful tool for the
diagnosis of bacterial meningitis. This is thought to be
due to either (a) the presence of mutations in the target
regions of probes or (b) competition among the 7 primer
pairs in mPCR/RLB.
In this study, the most common pathogen was Escherichia
coli, followed by Staphylococcus aureus, which is similar to
the result reported by Airede [23].
Our study demonstrates that the RT-PCR and mPCR/
RLB have the potential to identify pathogens better than
bacterial culture in the cases with bacterial meningitis.
Further studies will use RT-PCR and mPCR/RLB in larger
population with bacterial meningitis in future, especially
for the cases with negative CSF culture or other bacterial
pathogens.Conclusion
RT-PCR and mPCR/RLB assays are potentially useful and
reliable tools for the identification of neonatal bacterial
meningitis. Both methods were found to be much more
sensitive than culture particularly in the current series in
which 68% of subjects had prior exposure to antibiotics.
They detected the presence of pathogens in CSF samples
that yield negative culture results. Further studies are
necessary to confirm their utility and efficacy in optimiz-
ing the diagnosis and treatment of bacterial meningitis in
young children.Competing interests
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